The oral contraceptive market seems unstable due to candidate companies that will take over ‘Mercilon’

Bayer Korea unveiled that it is having active discussions to consider the current state of the Korea market with the corrective measure of ‘Mercilon’ with its headquarters.

On the 23^rd, the Fair Trade Commission (FTC), judging that Bayer Korea might limit competition in the domestic oral contraceptive market by taking over the MSD’s OTC business, decided to impose the corrective measure to sel...